Innospec Inc. (NASDAQ:IOSP - Get Free Report) shares reached a new 52-week low during trading on Wednesday . The company traded as low as $102.29 and last traded at $101.55, with a volume of 8113 shares changing hands. The stock had previously closed at $109.88.
Wall Street Analysts Forecast Growth
Separately, StockNews.com lowered Innospec from a "strong-buy" rating to a "buy" rating in a research report on Saturday, January 11th.
View Our Latest Analysis on IOSP
Innospec Stock Performance
The stock has a market capitalization of $2.58 billion, a P/E ratio of 72.86 and a beta of 1.09. The stock has a 50-day moving average price of $111.12 and a two-hundred day moving average price of $112.52.
Innospec (NASDAQ:IOSP - Get Free Report) last issued its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.05. The firm had revenue of $466.80 million for the quarter, compared to analyst estimates of $447.43 million. Innospec had a return on equity of 12.27% and a net margin of 1.93%. Equities analysts anticipate that Innospec Inc. will post 6.18 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in the company. Pacer Advisors Inc. purchased a new position in shares of Innospec in the 4th quarter valued at approximately $53,457,000. Raymond James Financial Inc. purchased a new position in shares of Innospec in the 4th quarter valued at approximately $20,992,000. Norges Bank purchased a new position in shares of Innospec in the 4th quarter valued at approximately $11,312,000. Royce & Associates LP lifted its stake in shares of Innospec by 9.3% in the 3rd quarter. Royce & Associates LP now owns 835,333 shares of the specialty chemicals company's stock valued at $94,468,000 after purchasing an additional 70,902 shares during the period. Finally, JPMorgan Chase & Co. lifted its stake in shares of Innospec by 24.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 266,688 shares of the specialty chemicals company's stock valued at $30,160,000 after purchasing an additional 52,640 shares during the period. Institutional investors own 96.64% of the company's stock.
Innospec Company Profile
(
Get Free Report)
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Further Reading
Before you consider Innospec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.
While Innospec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
